These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2439792)

  • 1. Clinical evaluation of bisoprolol in the treatment of extrasystoles and sinus tachycardia: an interim report.
    Sugimoto T; Hayakawa H; Osada H; Yamazaki N; Mori H; Yasuda H; Sakamoto A
    J Cardiovasc Pharmacol; 1986; 8 Suppl 11():S171-4. PubMed ID: 2439792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical evaluation of bisoprolol in patients with hypertension: interim report.
    Ikeda M; Inagaki Y; Iimura O; Kuramoto K; Takeda T
    J Cardiovasc Pharmacol; 1986; 8 Suppl 11():S139-42. PubMed ID: 2439785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electrophysiologic effects of an acute beta-blockade induced by bisoprolol in patients with supraventricular tachycardia as assessed by His-bundle electrograms.
    Neuss H; Conrad A; Mitrovic V; Schlepper M
    J Cardiovasc Pharmacol; 1986; 8 Suppl 11():S167-70. PubMed ID: 2439791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of cardioselective beta adrenergic blockade with intravenously administered tolamolol in the treatment of cardiac arrhythmias.
    Amsterdam EA; Lee G; Morrison S; Tonkin MJ; DeMaria AN; Mason DT
    Am J Cardiol; 1976 Aug; 38(2):195-9. PubMed ID: 7952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta-adrenergic blockade by nadolol in control of ventricular tachyarrhythmias.
    Nademanee K; Schleman MM; Singh BN; Morganroth J; Reid PR; Stritar JA
    Am Heart J; 1984 Oct; 108(4 Pt 2):1109-15. PubMed ID: 6207720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical evaluation of bisoprolol in patients with stable angina pectoris: a preliminary report.
    Kato K; Niitani H; Kanazawa T; Shimomura K; Toyama S
    J Cardiovasc Pharmacol; 1986; 8 Suppl 11():S154-9. PubMed ID: 2439788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of bisoprolol on cardiac performance in coronary heart disease.
    Maisch B; Borst U; Gerhards W; Wagner G
    Eur J Clin Pharmacol; 1989; 36(3):217-22. PubMed ID: 2568261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Esmolol in the treatment of severe tachycardia in neonatal tetanus.
    Luyt D; Dance M; Litmanovitch M; Mathivha R
    Anaesth Intensive Care; 1994 Jun; 22(3):303-4. PubMed ID: 7916178
    [No Abstract]   [Full Text] [Related]  

  • 9. Summary of short- and long-term studies with bisoprolol in coronary heart disease (CHD).
    Wagner G
    J Cardiovasc Pharmacol; 1986; 8 Suppl 11():S160-6. PubMed ID: 2439790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of esmolol during anesthesia to treat tachycardia and hypertension.
    Gold MI; Sacks DJ; Grosnoff DB; Herrington C; Skillman CA
    Anesth Analg; 1989 Feb; 68(2):101-4. PubMed ID: 2563314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Esmolol in the treatment of supraventricular tachyarrhythmias.
    Das G; Ferris J
    Can J Cardiol; 1988 May; 4(4):177-80. PubMed ID: 2899451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Esmolol: a new ultrashort-acting beta-adrenergic blocking agent for rapid control of heart rate in postoperative supraventricular tachyarrhythmias.
    Gray RJ; Bateman TM; Czer LS; Conklin CM; Matloff JM
    J Am Coll Cardiol; 1985 Jun; 5(6):1451-6. PubMed ID: 2860148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Inadequate, inappropriate sinus-node tachycardia: an old cardiac arrhythmia in a new perspective (II.): Our experiences with the pharmacological treatment].
    Borbola J; Földesi C; Kardos A; Som Z
    Orv Hetil; 2020 Nov; 161(46):1953-1958. PubMed ID: 33190126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of caffeine toxicity with esmolol.
    Price KR; Fligner DJ
    Ann Emerg Med; 1990 Jan; 19(1):44-6. PubMed ID: 1688693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therapy refractory sinus tachycardia following polytrauma].
    Wagner WL; Nitsch J; Manz M; Lüderitz B
    Z Kardiol; 1987 Aug; 76(8):514-6. PubMed ID: 3673169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular and antiarrhythmic effects of esmolol in children.
    Trippel DL; Wiest DB; Gillette PC
    J Pediatr; 1991 Jul; 119(1 Pt 1):142-7. PubMed ID: 1676729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute changes in renal function induced by bisoprolol, a new cardioselective beta-blocking agent.
    Glück Z; Reubi FC
    Eur J Clin Pharmacol; 1986; 31(1):107-11. PubMed ID: 2877882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ivabradine versus bisoprolol in the treatment of inappropriate sinus tachycardia: a long-term follow-up study.
    Martino A; Rebecchi M; Sette A; Cicogna F; Politano A; Sgueglia M; de Ruvo E; Volterrani M; Calo' L
    J Cardiovasc Med (Hagerstown); 2021 Dec; 22(11):892-900. PubMed ID: 34747925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose-effect relationship and long-term effects of bisoprolol in mild to moderate hypertension.
    Weiner L; Frithz G
    J Cardiovasc Pharmacol; 1986; 8 Suppl 11():S106-12. PubMed ID: 2439780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Propafenon, a new antiarrhythmic agent for the treatment of ectopic and rapid cardiac arrhythmias (author's transl)].
    Beck OA
    Med Klin; 1975 Jan; 70(3-2):95-101. PubMed ID: 48183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.